about
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsIntrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents.Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.Preclinical Effects of Antipsychotic Drugs.Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota.
P2860
Q33765864-654C4C1B-C1F8-4E92-BE28-C074053C52A9Q38626655-D90634FC-89B7-4618-AC49-8425C61CC825Q38842111-C53E4DC4-0D5C-4174-AA60-847142FF636EQ47165661-6FCFD273-A042-42DD-8818-5E352294F711Q47347005-B7DD7A33-1266-4004-9F6E-0FBA1F702C19Q53779310-07E824C7-1B0A-4526-B860-DF9A2EA2F13DQ54920392-5F9FEBBB-8388-4D18-952B-6106C700E5D7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modelling olanzapine-induced weight gain in rats.
@en
type
label
Modelling olanzapine-induced weight gain in rats.
@en
prefLabel
Modelling olanzapine-induced weight gain in rats.
@en
P2093
P2860
P1476
Modelling olanzapine-induced weight gain in rats.
@en
P2093
E M van der Zwaal
R A H Adan
S E la Fleur
S K Janhunen
P2860
P304
P356
10.1017/S146114571300093X
P577
2013-10-08T00:00:00Z